-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CCEClXV8avL9xXGHk4n+newIYVzuEm7aDUqPiApU2tPXTOlRRkXbNfRP1Xvd3f3T hVi8tp8Qo7FqtQoexxX26w== 0001181431-07-058548.txt : 20070921 0001181431-07-058548.hdr.sgml : 20070921 20070921174836 ACCESSION NUMBER: 0001181431-07-058548 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20070919 FILED AS OF DATE: 20070921 DATE AS OF CHANGE: 20070921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEKTAR THERAPEUTICS CENTRAL INDEX KEY: 0000906709 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943134940 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 INDUSTRIAL RD CITY: SAN CARLOS STATE: CA ZIP: 94070 BUSINESS PHONE: 6506313100 MAIL ADDRESS: STREET 1: 150 INDUSTRIAL ROAD CITY: SAN CARLOS STATE: CA ZIP: 94070 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS INC DATE OF NAME CHANGE: 19980723 FORMER COMPANY: FORMER CONFORMED NAME: INHALE THERAPEUTIC SYSTEMS DATE OF NAME CHANGE: 19940303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BROWN MICHAEL A/CA CENTRAL INDEX KEY: 0001204920 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-24006 FILM NUMBER: 071130161 BUSINESS ADDRESS: BUSINESS PHONE: 4089444000 MAIL ADDRESS: STREET 1: C/O QUANTUM CORP STREET 2: 1650 TECHNOLOGY DRIVE, SUITE 800 CITY: SAN JOSE STATE: CA ZIP: 95110 4 1 rrd173170.xml ANNUAL NON-EMPLOYEE DIRECTOR EQUITY AWARD X0202 4 2007-09-19 0 0000906709 NEKTAR THERAPEUTICS NKTR 0001204920 BROWN MICHAEL A/CA C/O NEKTAR THERAPEUTICS 201 INDUSTRIAL ROAD SAN CARLOS CA 94070 1 0 0 0 Stock Option (Right to Buy) 8.81 2007-09-19 4 A 0 15000 8.81 A 2007-09-19 Common Stock 15000 137500 D Restricted Stock Units 0.01 2007-09-19 4 A 0 5000 0.01 A Common Stock 5000 10000 D The Reporting Person is receiving this equity compensation under the Amended and Restated Compensation Plan for Non-Employee Directors. 1/12th of the shares shall vest per calendar month commencing September 19, 2007. The shares shall fully vest on September 19, 2008 provided that the Reporting Person continues his or her service as a director through such date. The shares of common stock shall vest upon the one year anniversary of the date of grant (or September 19, 2008), provided that the Reporting Person continues his or her service as a director through such date and further subject to the terms and conditions of the restricted stock unit agreement. Not applicable. /s/ Gil M. Labrucherie, Attorney-in-Fact 2007-09-21 -----END PRIVACY-ENHANCED MESSAGE-----